JW

Jiaxi WU

RP Regeneron Pharmaceuticals: 6 patents #198 of 810Top 25%
University Of Texas System: 5 patents #550 of 6,559Top 9%
📍 Elmsford, NY: #40 of 139 inventorsTop 30%
🗺 New York: #13,384 of 115,490 inventorsTop 15%
Overall (All Time): #431,984 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12319724 IL2 agonists and methods of use thereof Tong Zhang, Maria del Pilar MOLINA-PORTELA, Eric Smith, Chia-Yang Lin, Thomas Craig Meagher 2025-06-03
12215131 IgG Fc-IL2-Rα-IL2 fusions and methods of use thereof Tong Zhang, Maria del Pilar MOLINA-PORTELA, Eric Smith, Chia-Yang Lin, Thomas Craig Meagher 2025-02-04
12168681 Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereof Tong Zhang, Samuel Davis, Nicolin Bloch 2024-12-17
12091440 IL2 and peptide-MHC complex fusion proteins and methods of use thereof Tong Zhang, Maria del Pilar MOLINA-PORTELA, Eric Smith, Chia-Yang Lin, Thomas Craig Meagher 2024-09-17
11834485 IL-2 variants with reduced binding to IL-2 receptor alpha and uses thereof Tong Zhang, Samuel Davis, Nicolin Bloch 2023-12-05
11725034 IL2 agonists and methods of use thereof Tong Zhang, Maria del Pilar MOLINA-PORTELA, Eric Smith, Chia-Yang Lin, Thomas Craig Meagher 2023-08-15
11492368 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway Zhijian Chen, Lijun Sun, Heping Shi, Chuo Chen 2022-11-08
10696710 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway Zhijian Chen, Lijun Sun, Heping Shi, Chuo Chen 2020-06-30
10633411 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway Zhijian Chen, Lijun Sun, Heping Shi, Chuo Chen 2020-04-28
10508129 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway Zhijian Chen, Lijun Sun, Heping Shi, Chuo Chen 2019-12-17
10336786 Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway Zhijian Chen, Lijun Sun, Heping Shi, Chuo Chen 2019-07-02